AstraZeneca rolls out first Saphnelo DTC ads with ‘Here for More’ campaign for lupus mednews2022-05-11T20:50:49+00:00May 11th, 2022|Fierce Pharma|
Aurobindo Pharma slapped with Form 483 as FDA inspectors cite 6 findingsnews2022-05-11T20:29:09+00:00May 11th, 2022|Fierce Pharma|
PCI Pharma earmarks $100M to expand fill-finish operationsnews2022-05-11T17:01:54+00:00May 11th, 2022|Fierce Pharma|
Five Questions About Data Privacy To Ask Before 2023news2022-05-11T15:54:54+00:00May 11th, 2022|Fierce Pharma|
With expansion push in high gear, Cytiva opens new facility in Switzerlandnews2022-05-11T15:13:19+00:00May 11th, 2022|Fierce Pharma|
AbbVie, Teva looking to settle nationwide opioid litigation for $5B+: Bloombergnews2022-05-11T14:57:13+00:00May 11th, 2022|Fierce Pharma|
AbbVie, Teva looking to settle nationwide opioid litigation for $5B-plus: Bloombergnews2022-05-11T14:57:13+00:00May 11th, 2022|Fierce Pharma|
Roche’s Susvimo has its advantages, but eye doctors are sticking with Eyleanews2022-05-11T13:44:37+00:00May 11th, 2022|Fierce Pharma|
Takeda, bracing for Vyvanse patent loss, makes strides on debt goal and pivots its focus to launchesnews2022-05-11T13:30:19+00:00May 11th, 2022|Fierce Pharma|
Johnson & Johnson taps insiders to lead consumer health group after 2023 separationnews2022-05-11T13:25:47+00:00May 11th, 2022|Fierce Pharma|
